Keck School Faculty

Caryn Lerman

Caryn Lerman

Distinguished Professor of Psychiatry and the Behavioral Sciences and Psychology
H. Leslie Hoffman and Elaine S. Hoffman Chair in Cancer Research
Director USC Norris Comprehensive Cancer Center
Associate Dean for Cancer Programs
Cancer Center
1441 Eastlake Ave. Health Sciences Campus Los Angeles

Young adults' beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping Exp Clin Psychopharmacol. 2023 Apr; 31(2):455-463. . View in PubMed

ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients Ann Surg Oncol. 2023 Feb; 30(2):1028. . View in PubMed

Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels J Genet Couns. 2023 06; 32(3):706-716. . View in PubMed

Willingness to Use Commercial Nicotine Gums, Lozenges, and Gummies Among Nontobacco Using Adolescents in Southern California J Adolesc Health. 2023 02; 72(2):277-286. . View in PubMed

Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy BMC Med Res Methodol. 2023 04 29; 23(1):107. . View in PubMed

Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success Nicotine Tob Res. 2023 05 22; 25(6):1207-1211. . View in PubMed

Differences in intention to use flavored oral nicotine products among young adult e-cigarette users and non-users Prev Med Rep. 2022 Dec; 30:102027. . View in PubMed

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients Ann Surg Oncol. 2022 Sep 26. . View in PubMed

Development of Machine Learning Algorithms Incorporating Electronic Health Record Data, Patient-Reported Outcomes, or Both to Predict Mortality for Outpatients With Cancer JCO Clin Cancer Inform. 2022 12; 6:e2200073. . View in PubMed

Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes Mol Genet Genomic Med. 2022 10; 10(10):e2031. . View in PubMed

Examining the role of mitochondrial genetic variation in nicotine dependence Psychiatry Res. 2022 04; 310:114452. . View in PubMed

Asian Ethnic Subgroup Disparities in Delays of Surgical Treatment for Breast Cancer JNCI Cancer Spectr. 2022 02; 6(1). . View in PubMed

Balfour et alRespond. Am J Public Health. 2022 01; 112(1):e2-e3. . View in PubMed

Balfour et alRespond. Am J Public Health. 2022 01; 112(1):e5-e6. . View in PubMed

Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes Clin Transl Sci. 2022 01; 15(1):204-220. . View in PubMed

Leadership Diversity and Development in the Nation's Cancer Centers J Natl Cancer Inst. 2022 09 09; 114(9):1214-1221. . View in PubMed

Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes Pharmacogenet Genomics. 2022 06 01; 32(4):159-172. . View in PubMed

Assessing the Coverage of US Cancer Center Primary Catchment Areas Cancer Epidemiol Biomarkers Prev. 2022 05 04; 31(5):955-964. . View in PubMed

Differences in Young Adults' Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status Int J Environ Res Public Health. 2022 02 25; 19(5). . View in PubMed

Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV Psychol Addict Behav. 2021 Nov; 35(7):788-796. . View in PubMed

Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study Breast Cancer Res Treat. 2021 Jun; 187(3):831-841. . View in PubMed

Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations Clin Pharmacol Ther. 2021 10; 110(4):975-985. . View in PubMed

Balancing Consideration of the Risks and Benefits of E-Cigarettes Am J Public Health. 2021 09; 111(9):1661-1672. . View in PubMed

Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder Am J Addict. 2021 07; 30(4):382-388. . View in PubMed

Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent Mol Psychiatry. 2021 06; 26(6):2212-2223. . View in PubMed

A Genome-Wide Association Study of Nausea Incidence in Varenicline-Treated Cigarette Smokers Nicotine Tob Res. 2021 08 29; 23(10):1805-1809. . View in PubMed

Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies Drug Alcohol Depend. 2021 06 01; 223:108708. . View in PubMed

Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans Sci Rep. 2021 10 01; 11(1):19572. . View in PubMed

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients Cancer. 2021 04 15; 127(8):1275-1285. . View in PubMed

Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2126-2133. . View in PubMed

The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions Cancer Prev Res (Phila). 2020 03; 13(3):261-272. . View in PubMed

Neural cue reactivity during acute abstinence predicts short-term smoking relapse Addict Biol. 2020 03; 25(2):e12733. . View in PubMed

Impact of early nausea on varenicline adherence and smoking cessation Addiction. 2020 01; 115(1):134-144. . View in PubMed

Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity Addict Biol. 2020 01; 25(1):e12741. . View in PubMed

Brain Marker Links Stress and Nicotine Abstinence Nicotine Tob Res. 2020 05 26; 22(6):885-891. . View in PubMed

Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes Nicotine Tob Res. 2020 05 26; 22(6):900-909. . View in PubMed

Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain Drug Alcohol Depend. 2020 04 01; 209:107901. . View in PubMed

Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial Drug Alcohol Depend. 2020 05 01; 210:107967. . View in PubMed

Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse Nicotine Tob Res. 2020 07 16; 22(8):1277-1284. . View in PubMed

Evaluating the temporal relationships between withdrawal symptoms and smoking relapse Psychol Addict Behav. 2019 Mar; 33(2):105-116. . View in PubMed

Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial Drug Alcohol Depend. 2019 01 01; 194:244-251. . View in PubMed

Differences in the rate of nicotine metabolism among smokers with and without HIV AIDS. 2019 05 01; 33(6):1083-1088. . View in PubMed

Transcranial direct current brain stimulation decreases impulsivity in ADHD Brain Stimul. 2018 Sep - Oct; 11(5):974-981. . View in PubMed

Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial JAMA Netw Open. 2018 08; 1(4):e181346. . View in PubMed

A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine Cancer Epidemiol Biomarkers Prev. 2018 08; 27(8):882-891. . View in PubMed

Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al(2017). Addict Behav. 2018 04; 79:14-16. . View in PubMed

Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences Addiction. 2018 03; 113(3):509-523. . View in PubMed

Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism Pharmacogenet Genomics. 2018 Jan; 28(1):7-16. . View in PubMed

Appetite. 2018 12 01; 131:28-35. . View in PubMed

What a medical school chair wants from the dean J Healthc Leadersh. 2018; 10:33-44. . View in PubMed

Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes Drug Alcohol Depend. 2018 09 01; 190:72-81. . View in PubMed

Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? J Smok Cessat. 2017 Jun; 12(2):63-70.. View in PubMed

Measures and predictors of varenicline adherence in the treatment of nicotine dependence Addict Behav. 2017 12; 75:122-129. . View in PubMed

No Effect of Commercial Cognitive Training on Brain Activity, Choice Behavior, or Cognitive Performance J Neurosci. 2017 08 02; 37(31):7390-7402. . View in PubMed

Drug Alcohol Depend. 2016 Nov 01; 168:112-118. . View in PubMed

The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio Nicotine Tob Res. 2016 Apr; 18(4):491-5. . View in PubMed

Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking Brain Stimul. 2016 Mar-Apr; 9(2):191-6. . View in PubMed

Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking Pharmacol Biochem Behav. 2016 09; 148:1-7. . View in PubMed

Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio J Neuroimmune Pharmacol. 2016 09; 11(3):471-83. . View in PubMed

Nicotine withdrawal alters neural responses to psychosocial stress Psychopharmacology (Berl). 2016 07; 233(13):2459-67. . View in PubMed

Am J Addict. 2016 06; 25(4):291-6. . View in PubMed

Translational Research on Nicotine Dependence Curr Top Behav Neurosci. 2016; 28:121-50. . View in PubMed

Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate Biol Psychiatry. 2016 08 01; 80(3):190-7. . View in PubMed

Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence Nicotine Tob Res. 2016 Jan; 18(1):74-8. . View in PubMed

Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers Nicotine Tob Res. 2015 Dec; 17(12):1505-9. . View in PubMed

RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles BMC Genomics. 2015 Nov 23; 16:990. . View in PubMed

Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism J Nucl Med. 2015 Nov; 56(11):1724-9. . View in PubMed

Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1239-46. . View in PubMed

Working memory-related neural activity predicts future smoking relapse Neuropsychopharmacology. 2015 May; 40(6):1311-20. . View in PubMed

Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial Lancet Respir Med. 2015 Feb; 3(2):131-138. . View in PubMed

Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption PLoS One. 2015; 10(7):e0126113. . View in PubMed

Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking PLoS One. 2015; 10(5):e0128109. . View in PubMed

Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1773-82. . View in PubMed

Age-related differences in working memory deficits during nicotine withdrawal Addict Biol. 2014 Sep; 19(5):907-17. . View in PubMed

Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence Mol Psychiatry. 2014 Jul; 19(7):801-10. . View in PubMed

Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function JAMA Psychiatry. 2014 May; 71(5):523-30. . View in PubMed

Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome Drug Alcohol Depend. 2014 May 01; 138:109-17. . View in PubMed

Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment Neuropharmacology. 2014 Jan; 76 Pt B:581-91. . View in PubMed

An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation Psychopharmacology (Berl). 2014 Jan; 231(1):1-11. . View in PubMed

Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study Drug Alcohol Depend. 2013 Dec 15; 133(3):852-6. . View in PubMed

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion Addiction. 2013 Dec; 108(12):2202-11. . View in PubMed

Association of abstinence-induced alterations in working memory function and COMT genotype in smokers Psychopharmacology (Berl). 2013 Dec; 230(4):653-62. . View in PubMed

Pharmacogenomics J. 2013 Dec; 13(6):538-43. . View in PubMed

No untoward effects of smoking cues in anti-smoking public service announcements Drug Alcohol Depend. 2013 Nov 01; 133(1):279-82. . View in PubMed

Effects of bupropion on cognitive performance during initial tobacco abstinence Drug Alcohol Depend. 2013 Nov 01; 133(1):283-6. . View in PubMed

Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications Addiction. 2013 Nov; 108(11):1962-8. . View in PubMed

Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls Neuropsychopharmacology. 2013 Nov; 38(12):2327-37. . View in PubMed

Brain activity and emotional processing in smokers treated with varenicline Addict Biol. 2013 Jul; 18(4):732-8. . View in PubMed

The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence Nicotine Tob Res. 2013 Jul; 15(7):1190-200. . View in PubMed

Biomarkers for smoking cessation Clin Pharmacol Ther. 2013 Jun; 93(6):526-38. . View in PubMed

Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements J Neurosci. 2013 Apr 24; 33(17):7420-7. . View in PubMed

The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):708-18. . View in PubMed

Effects of smoking cues and argument strength of antismoking advertisements on former smokers' self-efficacy, attitude, and intention to refrain from smoking Nicotine Tob Res. 2013 Feb; 15(2):527-33. . View in PubMed

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies Pharmacogenet Genomics. 2013 Feb; 23(2):94-103. . View in PubMed

Gender-stratified gene and gene-treatment interactions in smoking cessation Pharmacogenomics J. 2012 Dec; 12(6):521-32. . View in PubMed

Smoking in response to negative mood in men versus women as a function of distress tolerance Nicotine Tob Res. 2012 Dec; 14(12):1418-25. . View in PubMed

Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study Drug Alcohol Depend. 2012 Nov 01; 126(1-2):263-7. . View in PubMed

µ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief Psychopharmacology (Berl). 2012 Aug; 222(4):701-8. . View in PubMed

Comparative dynamics of four smoking withdrawal symptom scales Addiction. 2012 Aug; 107(8):1501-11. . View in PubMed

DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers Pharmacogenet Genomics. 2012 Jul; 22(7):551-4. . View in PubMed

Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation Neuropsychopharmacology. 2012 Jun; 37(7):1683-8. . View in PubMed

Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation Addict Behav. 2012 Apr; 37(4):565-8. . View in PubMed

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials Neuropsychopharmacology. 2012 Feb; 37(3):641-50. . View in PubMed

Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes Hum Genet. 2012 Jan 31. . View in PubMed

A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial Health Commun. 2011 Dec; 26(8):735-42. . View in PubMed

Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs Genes Brain Behav. 2011 Nov; 10(8):862-7. . View in PubMed

The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy Addiction. 2011 Oct; 106(10):1835-45. . View in PubMed

Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers Nicotine Tob Res. 2011 Jun; 13(6):498-503. . View in PubMed

Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers Proc Natl Acad Sci U S A. 2011 May 31; 108(22):9268-73. . View in PubMed

Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs Nicotine Tob Res. 2011 Apr; 13(4):282-90. . View in PubMed

Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics Clin Pharmacol Ther. 2011 Mar; 89(3):460-3. . View in PubMed

Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level Cancer Epidemiol Biomarkers Prev. 2011 Feb; 20(2):234-8. . View in PubMed

A new chapter in the history of SRNT: the formation of the European chapter of SRNT (SRNT-E)--a letter from the Presidents of SRNT and SRNT Europe Nicotine Tob Res. 2010 Dec; 12(12):1181-2. . View in PubMed

Cross-validation of a new procedure for early screening of smoking cessation medications in humans Clin Pharmacol Ther. 2010 Jul; 88(1):109-14. . View in PubMed

Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers Hum Genet. 2010 Jun; 127(6):691-8. . View in PubMed

Mouse model predicts effects of smoking and varenicline on event-related potentials in humans Nicotine Tob Res. 2010 Jun; 12(6):589-97. . View in PubMed

Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence Neuropsychopharmacology. 2010 May; 35(6):1374-82. . View in PubMed

Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence Psychopharmacology (Berl). 2010 May; 210(1):45-51. . View in PubMed

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy Clin Pharmacol Ther. 2010 May; 87(5):553-7. . View in PubMed

The public health utility of genome-wide association study results for smoking behavior Genome Med. 2010 Apr 27; 2(4):26. . View in PubMed

Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers Biol Psychiatry. 2010 Apr 15; 67(8):715-21. . View in PubMed

Reinforcing effects of smoking: more than a feeling Biol Psychiatry. 2010 Apr 15; 67(8):699-701. . View in PubMed

Nicotine vaccines: will smokers take a shot at quitting? Nicotine Tob Res. 2010 Apr; 12(4):390-7.. View in PubMed

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial Ann Intern Med. 2010 Feb 02; 152(3):144-51. . View in PubMed

Working memory deficits predict short-term smoking resumption following brief abstinence Drug Alcohol Depend. 2010 Jan 01; 106(1):61-4. . View in PubMed

Transdisciplinary Tobacco Use Research Centers: research achievements and future implications Nicotine Tob Res. 2009 Oct; 11(10):1231-44. . View in PubMed

Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2608-12. . View in PubMed

Dopamine genes and nicotine dependence in treatment-seeking and community smokers Neuropsychopharmacology. 2009 Sep; 34(10):2252-64. . View in PubMed

Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype Mol Psychiatry. 2009 Aug; 14(8):820-6. . View in PubMed

A systems biology network model for genetic association studies of nicotine addiction and treatment Pharmacogenet Genomics. 2009 Jul; 19(7):538-51. . View in PubMed

Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior Proc Natl Acad Sci U S A. 2009 Jun 30; 106(26):10847-52. . View in PubMed

Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent Nucl Med Commun. 2009 Apr; 30(4):314-8. . View in PubMed

Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes Nicotine Tob Res. 2009 Mar; 11(3):293-302. . View in PubMed

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study Pharmacol Biochem Behav. 2009 Mar; 92(1):6-11. . View in PubMed

Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence J Psychopharmacol. 2009 Mar; 23(2):168-76. . View in PubMed

The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions Nicotine Tob Res. 2009 Mar; 11(3):254-61. . View in PubMed

Varenicline improves mood and cognition during smoking abstinence Biol Psychiatry. 2009 Jan 15; 65(2):144-9. . View in PubMed

Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking Drug Alcohol Depend. 2009 Jan 01; 99(1-3):47-57. . View in PubMed

Nicotine dependence: biology, behavior, and treatment Annu Rev Med. 2009; 60:247-60. . View in PubMed

Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users Nicotine Tob Res. 2009 Jan; 11(1):99-105. . View in PubMed

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes J Neurogenet. 2009; 23(3):252-61. . View in PubMed

Severity of tobacco abstinence symptoms varies by time of day Nicotine Tob Res. 2009 Jan; 11(1):84-91. . View in PubMed

Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment Pharmacogenomics J. 2008 Dec; 8(6):391-9. . View in PubMed

The STAGE cohort: a prospective study of tobacco use among Swedish twins Nicotine Tob Res. 2008 Dec; 10(12):1727-35. . View in PubMed

Neuroimaging, genetics and the treatment of nicotine addiction Behav Brain Res. 2008 Nov 21; 193(2):159-69. . View in PubMed

Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):2903-5. . View in PubMed

A placebo-controlled trial of modafinil for nicotine dependence Drug Alcohol Depend. 2008 Nov 01; 98(1-2):86-93. . View in PubMed

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85. . View in PubMed

Initial nicotine sensitivity in humans as a function of impulsivity Psychopharmacology (Berl). 2008 Nov; 200(4):529-44. . View in PubMed

Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation Hum Mol Genet. 2008 Sep 15; 17(18):2834-48. . View in PubMed

Identification of pharmacogenetic markers in smoking cessation therapy Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):712-9. . View in PubMed

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion Clin Pharmacol Ther. 2008 Sep; 84(3):320-5. . View in PubMed

Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers Behav Pharmacol. 2008 Sep; 19(5-6):630-40. . View in PubMed

Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood Behav Pharmacol. 2008 Sep; 19(5-6):641-9. . View in PubMed

Snus use and other correlates of smoking cessation in the Swedish Twin Registry Psychol Med. 2008 Sep; 38(9):1299-308. . View in PubMed

Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers Nicotine Tob Res. 2008 Aug; 10(8):1335-45. . View in PubMed

Development of procedures for early screening of smoking cessation medications in humans Clin Pharmacol Ther. 2008 Aug; 84(2):216-21. . View in PubMed

Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment Cancer Prev Res (Phila). 2008 Jul; 1(2):80-3. . View in PubMed

Nicotine abstinence-induced cerebral blood flow changes by genotype Neurosci Lett. 2008 Jun 27; 438(3):275-80. . View in PubMed

Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics Nicotine Tob Res. 2008 Jun; 10(6):1037-45. . View in PubMed

Molecular genetics of successful smoking cessation: convergent genome-wide association study results Arch Gen Psychiatry. 2008 Jun; 65(6):683-93. . View in PubMed

Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM) Nicotine Tob Res. 2008 Jun; 10(6):1009-20. . View in PubMed

Increase in anger symptoms after smoking cessation predicts relapse Drug Alcohol Depend. 2008 May 01; 95(1-2):173-6. . View in PubMed

J Subst Abuse Treat. 2008 Mar; 34(2):234-41. . View in PubMed

Spiral computed tomography and lung cancer: science, the media, and public opinion J Clin Oncol. 2007 Dec 20; 25(36):5695-7. . View in PubMed

Neural substrates of abstinence-induced cigarette cravings in chronic smokers J Neurosci. 2007 Dec 19; 27(51):14035-40. . View in PubMed

Associations between Cloninger's temperament dimensions and acute tobacco withdrawal Addict Behav. 2007 Dec; 32(12):2976-89. . View in PubMed

Genetics and smoking cessation improving outcomes in smokers at risk Am J Prev Med. 2007 Dec; 33(6 Suppl):S398-405. . View in PubMed

Enhanced identification of smoking-related words during the attentional blink in smokers Addict Behav. 2007 Dec; 32(12):3077-82. . View in PubMed

Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial Nicotine Tob Res. 2007 Nov; 9(11):1237-41. . View in PubMed

Translating basic science to improve pharmacotherapy for nicotine dependence Nicotine Tob Res. 2007 Nov; 9 Suppl 4:S583-98. . View in PubMed

Treating tobacco dependence in women J Womens Health (Larchmt). 2007 Oct; 16(8):1211-8. . View in PubMed

Genetics and smoking behavior Curr Psychiatry Rep. 2007 Oct; 9(5):349-57. . View in PubMed

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial Biol Psychiatry. 2007 Sep 15; 62(6):635-41. . View in PubMed

Translational research in medication development for nicotine dependence Nat Rev Drug Discov. 2007 Sep; 6(9):746-62. . View in PubMed

CHRNA4 and tobacco dependence: from gene regulation to treatment outcome Arch Gen Psychiatry. 2007 Sep; 64(9):1078-86. . View in PubMed

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation Nicotine Tob Res. 2007 Aug; 9(8):821-33. . View in PubMed

CREB1 haplotypes and the relative reinforcing value of nicotine Mol Psychiatry. 2007 Jul; 12(7):615-7. . View in PubMed

CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1312-4. . View in PubMed

An association of CYP2A6 genotype and smoking topography Nicotine Tob Res. 2007 Apr; 9(4):511-8. . View in PubMed

Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures Exp Clin Psychopharmacol. 2007 Feb; 15(1):21-36. . View in PubMed

New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure Drug Alcohol Depend. 2007 Jan 12; 86(2-3):294-300. . View in PubMed

Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials Nicotine Tob Res. 2007 12; 9(12):1251-7. . View in PubMed

Pharmacogenetics and smoking cessation with nicotine replacement therapy CNS Drugs. 2007; 21(7):525-33. . View in PubMed

Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence Biol Psychiatry. 2007 Jan 01; 61(1):111-8. . View in PubMed

Can pharmacogenetics help smokers quit? Pharmacogenomics. 2006 Dec; 7(8):1137-40.. View in PubMed

No evidence for a major role of polymorphisms during bupropion treatment Obesity (Silver Spring). 2006 Nov; 14(11):1863-7. . View in PubMed

Association of OPRM1 A118G variant with the relative reinforcing value of nicotine Psychopharmacology (Berl). 2006 Oct; 188(3):355-63. . View in PubMed

Current and emerging pharmacotherapies for treating tobacco dependence Expert Opin Emerg Drugs. 2006 Sep; 11(3):429-44. . View in PubMed

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation Clin Pharmacol Ther. 2006 Jun; 79(6):600-8. . View in PubMed

Helping smokers quit through pharmacogenetics LDI Issue Brief. 2006 May-Jun; 11(6):1-4. . View in PubMed

Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence Pharmacogenomics J. 2006 May-Jun; 6(3):194-9. . View in PubMed

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy Mol Psychiatry. 2006 Apr; 11(4):400-9. . View in PubMed

Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes Psychol Addict Behav. 2006 Mar; 20(1):80-4. . View in PubMed

Medication screening for smoking cessation: a proposal for new methodologies Psychopharmacology (Berl). 2006 Mar; 184(3-4):628-36. . View in PubMed

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial Cancer Epidemiol Biomarkers Prev. 2006 Feb; 15(2):398-400. . View in PubMed

A randomized controlled trial of financial incentives for smoking cessation Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):12-8. . View in PubMed

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials Neuropsychopharmacology. 2006 Jan; 31(1):231-42. . View in PubMed

Is Swedish snus associated with smoking initiation or smoking cessation? Tob Control. 2005 Dec; 14(6):422-4.. View in PubMed

A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients Ann Behav Med. 2005 Aug; 30(1):1-11. . View in PubMed

Pharmacotherapy and pharmacogenetics of nicotine dependence Am J Psychiatry. 2005 Aug; 162(8):1441-51. . View in PubMed

Reduced nicotine reward in obesity: cross-comparison in human and mouse Psychopharmacology (Berl). 2005 Jul; 180(2):306-15. . View in PubMed

Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1384-9. . View in PubMed

Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy J Subst Abuse Treat. 2005 Jun; 28(4):297-304. . View in PubMed

Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm Psychopharmacology (Berl). 2005 Jun; 180(1):41-8. . View in PubMed

Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women Pharmacogenet Genomics. 2005 Jun; 15(6):393-8. . View in PubMed

Behavioral consequences of testing for obesity risk Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1485-9. . View in PubMed

Smoking cessation treatment: pharmacogenetic assessment Curr Opin Mol Ther. 2005 Jun; 7(3):202-8. . View in PubMed

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1003-7. . View in PubMed

Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers Mol Psychiatry. 2005 Apr; 10(4):407-14. . View in PubMed

Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion Nicotine Tob Res. 2005 Apr; 7(2):257-68. . View in PubMed

BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships Am J Med Genet A. 2005 Mar 01; 133A(2):165-9. . View in PubMed

Barriers to translating emerging genetic research on smoking into clinical practicePerspectives of primary care physicians. J Gen Intern Med. 2005 Feb; 20(2):131-8. . View in PubMed

Treating tobacco dependence: state of the science and new directions J Clin Oncol. 2005 Jan 10; 23(2):311-23. . View in PubMed

Effects of different nicotine replacement therapies on postcessation psychological responses Addict Behav. 2005 Jan; 30(1):9-17. . View in PubMed

Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample Ann Behav Med. 2004 Dec; 28(3):211-25. . View in PubMed

Effect of bupropion on depression symptoms in a smoking cessation clinical trial Psychol Addict Behav. 2004 Dec; 18(4):362-6. . View in PubMed

Smoking topography predicts abstinence following treatment with nicotine replacement therapy Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1800-4. . View in PubMed

BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention Am J Med Genet A. 2004 Oct 15; 130A(3):221-7. . View in PubMed

Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations Arch Intern Med. 2004 Sep 27; 164(17):1881-7. . View in PubMed

Changes in food reward following smoking cessation: a pharmacogenetic investigation Psychopharmacology (Berl). 2004 Aug; 174(4):571-7. . View in PubMed

Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations J Behav Med. 2004 Aug; 27(4):373-92. . View in PubMed

Relationship between education and delay discounting in smokers Addict Behav. 2004 Aug; 29(6):1171-5. . View in PubMed

Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations Nicotine Tob Res. 2004 Aug; 6(4):675-88. . View in PubMed

Interacting effects of genetic predisposition and depression on adolescent smoking progression Am J Psychiatry. 2004 Jul; 161(7):1224-30. . View in PubMed

Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers Am J Clin Nutr. 2004 Jul; 80(1):82-8. . View in PubMed

Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers Nicotine Tob Res. 2004 Jun; 6(3):501-7. . View in PubMed

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients J Clin Oncol. 2004 May 15; 22(10):1823-9. . View in PubMed

Food hedonics and reinforcement as determinants of laboratory food intake in smokers Physiol Behav. 2004 May; 81(3):511-7. . View in PubMed

Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):875-81. . View in PubMed

Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients Psychooncology. 2004 May; 13(5):346-58. . View in PubMed

Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine Tob Res. 2004 Apr; 6(2):357-66.. View in PubMed

Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial Ann Intern Med. 2004 Mar 16; 140(6):426-33. . View in PubMed

Cigarette smoking practices among American college students: review and future directions J Am Coll Health. 2004 Mar-Apr; 52(5):203-10. . View in PubMed

Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome Psychopharmacology (Berl). 2004 Mar; 172(3):271-6. . View in PubMed

Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment Head Neck. 2004 Mar; 26(3):278-86. . View in PubMed

Using logistic regression to estimate delay-discounting functions Behav Res Methods Instrum Comput. 2004 Feb; 36(1):41-51. . View in PubMed

Influence of methylphenidate on eating in obese men Obes Res. 2004 Feb; 12(2):224-32. . View in PubMed

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling Nicotine Tob Res. 2004 Feb; 6(1):27-37. . View in PubMed

Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms Pharmacogenomics J. 2004; 4(2):102-9. . View in PubMed

Genetics and drug use as a complex phenotype Subst Use Misuse. 2004; 39(10-12):1515-69. . View in PubMed

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial Pharmacogenomics J. 2004; 4(3):184-92. . View in PubMed

Transdisciplinary science applied to the evaluation of treatments for tobacco use Nicotine Tob Res. 2003 Dec; 5 Suppl 1:S89-99. . View in PubMed

Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers Nicotine Tob Res. 2003 Dec; 5 Suppl 1:S11-9. . View in PubMed

Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective Nicotine Tob Res. 2003 Dec; 5 Suppl 1:S55-69. . View in PubMed

Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling Drug Alcohol Depend. 2003 Nov 24; 72(2):123-31. . View in PubMed

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing J Clin Oncol. 2003 Nov 01; 21(21):4034-41. . View in PubMed

Frontiers in cancer prevention research Cancer Res. 2003 Sep 15; 63(18):5649-55. . View in PubMed

Genes, smoking, and treatment response Am J Health Syst Pharm. 2003 Sep 15; 60(18):1911. . View in PubMed

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial Health Psychol. 2003 Sep; 22(5):541-8. . View in PubMed

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain Neuropharmacology. 2003 Jul; 45(1):122-32. . View in PubMed

Comparison between two measures of delay discounting in smokers Exp Clin Psychopharmacol. 2003 May; 11(2):131-8. . View in PubMed

Individual differences in nicotine intake per cigarette Cancer Epidemiol Biomarkers Prev. 2003 May; 12(5):468-71. . View in PubMed

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing Am J Med Genet A. 2003 Apr 30; 118A(3):201-9. . View in PubMed

Elucidating the role of genetic factors in smoking behavior and nicotine dependence Am J Med Genet B Neuropsychiatr Genet. 2003 Apr 01; 118B(1):48-54. . View in PubMed

Health Commun. 2003; 15(4):499-513. . View in PubMed

Dopamine transporter genotype as a risk factor for obesity in African-American smokers Obes Res. 2002 Dec; 10(12):1232-40. . View in PubMed

Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res. 2002 Aug; 4(3):247-9.. View in PubMed

Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents J Am Acad Child Adolesc Psychiatry. 2002 Jul; 41(7):799-805. . View in PubMed

Mediating mechanisms for the impact of bupropion in smoking cessation treatment Drug Alcohol Depend. 2002 Jul 01; 67(2):219-23. . View in PubMed

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes J Clin Oncol. 2002 Jun 01; 20(11):2701-12. . View in PubMed

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results Am J Med Genet. 2002 Jan 15; 107(2):143-50. . View in PubMed

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample J Clin Oncol. 2002 Jan 15; 20(2):514-20. . View in PubMed

Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer Breast Cancer Res Treat. 2002 Jan; 71(2):103-12. . View in PubMed

Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents J Health Care Law Policy. 2002; 6(1):73-88. . View in PubMed

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women Cancer. 2001 Aug 15; 92(4):932-40. . View in PubMed

Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants Psychooncology. 2001 Jul-Aug; 10(4):336-46. . View in PubMed

Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations Cancer Epidemiol Biomarkers Prev. 2001 May; 10(5):475-81. . View in PubMed

BRCA1/2 testing: complex themes in result interpretation J Clin Oncol. 2001 May 01; 19(9):2555-65. . View in PubMed

Genetic risk and behavioural change BMJ. 2001 Apr 28; 322(7293):1056-9. . View in PubMed

Nicotine metabolism and CYP2D6 phenotype in smokers Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):261-3. . View in PubMed

Parental communication of BRCA1/2 genetic test results to children Patient Educ Couns. 2001 Mar; 42(3):213-24. . View in PubMed

Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population Am J Med Genet. 2001 Feb 01; 98(4):336-42. . View in PubMed

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studyHereditary Breast Cancer Clinical Study Group. Lancet. 2000 Dec 02; 356(9245):1876-81. . View in PubMed

Intention to be tested for prostate cancer risk among African-American men Cancer Epidemiol Biomarkers Prev. 2000 Dec; 9(12):1323-8. . View in PubMed

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families Am J Med Genet. 2000 Aug 14; 93(4):257-63. . View in PubMed

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing Prev Med. 2000 Jul; 31(1):75-80. . View in PubMed

Spiritual faith and genetic testing decisions among high-risk breast cancer probands Cancer Epidemiol Biomarkers Prev. 2000 Apr; 9(4):381-5. . View in PubMed

Adoption of a health education intervention for family members of breast cancer patients Am J Prev Med. 2000 Apr; 18(3):189-98. . View in PubMed

Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence Mol Psychiatry. 2000 Mar; 5(2):189-92. . View in PubMed

Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancerPart II: Hereditary nonpolyposis colorectal carcinoma as a model. Cancer. 1999 Dec 01; 86(11 Suppl):2457-63. . View in PubMed

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2 Lancet. 1999 Nov 27; 354(9193):1846-50. . View in PubMed

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations Br J Cancer. 1999 Sep; 81(1):179-83. . View in PubMed

Bilateral prophylactic mastectomy decision making: A vignette study Prev Med. 1999 Sep; 29(3):216-21. . View in PubMed

Genetic counselling for hereditary breast cancer Lancet. 1999 Jun 26; 353(9171):2176-7. . View in PubMed

A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use Am J Public Health. 1999 Jun; 89(6):924-6. . View in PubMed

Genetic testing in families with hereditary nonpolyposis colon cancer JAMA. 1999 May 05; 281(17):1618-22. . View in PubMed

Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing Cancer Epidemiol Biomarkers Prev. 1999 Apr; 8(4 Pt 2):361-7. . View in PubMed

Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups Cancer Epidemiol Biomarkers Prev. 1999 Apr; 8(4 Pt 2):329-36. . View in PubMed

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer Cancer Genet Cytogenet. 1999 Mar; 109(2):91-8. . View in PubMed

Evidence suggesting the role of specific genetic factors in cigarette smoking Health Psychol. 1999 Jan; 18(1):14-20. . View in PubMed

Patterns of breast cancer screening among lesbians at increased risk for breast cancer Women Health. 1999; 29(4):35-55. . View in PubMed

Risk communication in genetic testing for cancer susceptibility J Natl Cancer Inst Monogr. 1999; (25):59-66. . View in PubMed

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians Cancer Epidemiol Biomarkers Prev. 1998 Jun; 7(6):453-8. . View in PubMed

Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes J Natl Cancer Inst. 1998 May 20; 90(10):761-6. . View in PubMed

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing J Clin Oncol. 1998 May; 16(5):1650-4. . View in PubMed

Informed consent for BRCA1 and BRCA2 testing Breast Dis. 1998 Apr; 10(1-2):99-114. . View in PubMed

The role of the serotonin transporter gene in cigarette smoking Cancer Epidemiol Biomarkers Prev. 1998 Mar; 7(3):253-5. . View in PubMed

The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients Ann Behav Med. 1998; 20(1):7-12. . View in PubMed

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol. 1998 Jan; 16(1):133-8.. View in PubMed

Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene Health Psychol. 1998 Jan; 17(1):56-62. . View in PubMed

Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility Am J Med Genet. 1997 Dec 19; 73(3):296-303. . View in PubMed

Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications Cancer Epidemiol Biomarkers Prev. 1997 Dec; 6(12):987-91. . View in PubMed

Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial Addict Behav. 1997 Nov-Dec; 22(6):741-51. . View in PubMed

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk Patient Educ Couns. 1997 Sep-Oct; 32(1-2):51-62. . View in PubMed

Translational behavioral research in cancer genetics Prev Med. 1997 Sep-Oct; 26(5 Pt 2):S65-9. . View in PubMed

Psychologic aspects of cancer genetic testing: a research update for clinicians Cancer. 1997 Aug 01; 80(3 Suppl):569-75. . View in PubMed

A descriptive study of BRCA1 testing and reactions to disclosure of test results Cancer. 1997 Jun 01; 79(11):2219-28. . View in PubMed

The influence of psychological distress on use of genetic testing for cancer risk J Consult Clin Psychol. 1997 Jun; 65(3):414-20. . View in PubMed

Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy J Natl Cancer Inst. 1997 May 21; 89(10):703-8. . View in PubMed

Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patientsHigh-Risk Breast Cancer Consortium. Psychosomatics. 1997 May-Jun; 38(3):253-61. . View in PubMed

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing J Natl Cancer Inst. 1997 Jan 15; 89(2):148-57. . View in PubMed

Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal Ann Behav Med. 1997; 19(4):370-7. . View in PubMed

Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change Health Psychol. 1997 Jan; 16(1):87-99. . View in PubMed

Gender and ethnic differences in readiness to change smoking behavior Womens Health. 1997; 3(2):139-50. . View in PubMed

Cancer genetic susceptibility testing: ethical and policy implications for future research and clinical practiceCancer Genetic Studies Consortium, National Institutes of Health. J Law Med Ethics. 1997; 25(4):243-51230. . View in PubMed

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families Nat Med. 1996 Nov; 2(11):1179-83. . View in PubMed

Black-white differences in factors influencing mammography use among employed female health maintenance organization members Ethn Health. 1996 Sep; 1(3):207-20. . View in PubMed

A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing J Natl Cancer Inst. 1996 Jul 03; 88(13):872-82. . View in PubMed

BRCA1 testing in families with hereditary breast-ovarian cancerA prospective study of patient decision making and outcomes. JAMA. 1996 Jun 26; 275(24):1885-92. . View in PubMed

Who participates? Who declines? High Risk Breast Cancer Consortium. Cancer. 1996 Jun 01; 77(11):2348-55. . View in PubMed

Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers Int J Cancer. 1996 Feb 20; 69(1):58-61. . View in PubMed

Emotional and behavioral responses to genetic testing for susceptibility to cancer Oncology (Williston Park). 1996 Feb; 10(2):191-59; discussion 200-2. . View in PubMed

Ethnic differences in risk perception among women at increased risk for breast cancer Breast Cancer Res Treat. 1996; 40(1):25-35. . View in PubMed

Investigation of mechanisms linking depressed mood to nicotine dependence Addict Behav. 1996 Jan-Feb; 21(1):9-19. . View in PubMed

Gail model breast cancer risk components are poor predictors of risk perception and screening behavior Breast Cancer Res Treat. 1996; 41(1):59-70. . View in PubMed

Interest in genetic testing among first-degree relatives of breast cancer patients Am J Med Genet. 1995 Jul 03; 57(3):385-92. . View in PubMed

Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patientsThe High Risk Breast Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug; 4(5):561-5. . View in PubMed

Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer Health Psychol. 1995 May; 14(3):232-5. . View in PubMed

Utilization of ovarian cancer screening by women at increased risk Cancer Epidemiol Biomarkers Prev. 1995 Apr-May; 4(3):269-73. . View in PubMed

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):169-73. . View in PubMed

Effects of individualized breast cancer risk counseling: a randomized trial J Natl Cancer Inst. 1995 Feb 15; 87(4):286-92. . View in PubMed

Genetic testing for cancer predisposition: behavioral science issues J Natl Cancer Inst Monogr. 1995; (17):63-6. . View in PubMed

Recruiting high risk women into a breast cancer health promotion trial Cancer Epidemiol Biomarkers Prev. 1994 Apr-May; 3(3):271-6. . View in PubMed

Attitudes about genetic testing for breast-ovarian cancer susceptibility J Clin Oncol. 1994 Apr; 12(4):843-50. . View in PubMed

Psychological issues in genetic testing for breast cancer susceptibility Arch Intern Med. 1994 Mar 28; 154(6):609-16. . View in PubMed

Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior J Natl Cancer Inst Monogr. 1994; (16):171-6. . View in PubMed

Adherence and psychological adjustment among women at high risk for breast cancer Breast Cancer Res Treat. 1993 Nov; 28(2):145-55. . View in PubMed

Communication between patients with breast cancer and health care providersDeterminants and implications. Cancer. 1993 Nov 01; 72(9):2612-20. . View in PubMed

Biological markers in smoking cessation treatment Semin Oncol. 1993 Aug; 20(4):359-67. . View in PubMed

Mammography adherence and psychological distress among women at risk for breast cancer J Natl Cancer Inst. 1993 Jul 07; 85(13):1074-80. . View in PubMed

Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates Prev Med. 1993 Mar; 22(2):284-92. . View in PubMed

Factors associated with adherence to breast cancer screening among working women J Occup Med. 1992 Nov; 34(11):1071-8. . View in PubMed

Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial Cancer Epidemiol Biomarkers Prev. 1992 Jul-Aug; 1(5):413-6. . View in PubMed

The impact of mailing psychoeducational materials to women with abnormal mammograms Am J Public Health. 1992 May; 82(5):729-30. . View in PubMed

AIDS concerns among low-risk heterosexuals: the other side of the epidemic Med Care. 1992 Mar; 30(3):276-81. . View in PubMed

Telephone counseling improves adherence to colposcopy among lower-income minority women J Clin Oncol. 1992 Feb; 10(2):330-3. . View in PubMed

Adverse psychologic consequences of positive cytologic cervical screening Am J Obstet Gynecol. 1991 Sep; 165(3):658-62. . View in PubMed

Cancer risk notification: psychosocial and ethical implications J Clin Oncol. 1991 Jul; 9(7):1275-82. . View in PubMed

Psychological side effects of breast cancer screening Health Psychol. 1991; 10(4):259-67. . View in PubMed

Factors associated with inadequate cervical cancer screening among lower income primary care patients J Am Board Fam Pract. 1990 Jul-Sep; 3(3):151-6. . View in PubMed

Dr. Caryn Lerman is the Director of the USC Norris Comprehensive Cancer Center, Associate Dean for Cancer Programs, and the H. Leslie and Elaine S. Hoffman Cancer Research Chair at the Keck School of Medicine of USC. She is recognized for her cancer prevention research that bridges the fields of neuroscience, genomics, pharmacology, and population science. A major unifying focus of her research is biology-driven science to reduce cancer risk behaviors. This work has spawned novel lines of investigation, including: the behavioral epidemiology of cancer genetic susceptibility testing; pharmacogenomic approaches to tobacco dependence leading to the first prospective stratified pharmacogenomic trial in this area; and neuroscience-based interventions to reduce tobacco dependence.

An elected member of the National Academy of Medicine, Dr. Lerman has served as a member of the NCI Board of Scientific Advisors, the National Human Genome Research Advisory Council, and the National Institutes on Drug Abuse Advisory Council. She is the current Vice President/President-Elect of the Association of American Cancer Institutes and a past president of the Society for Research on Nicotine and Tobacco. Additional awards and honors include the American Cancer Society Cancer Control Award, the American Society of Preventive Oncology Joseph Cullen Award, the Alton Ochsner Award Relating Smoking and Health, the NIH Matilda White Riley Award, and the Los Angeles Business Journal award for Women Leaders in Healthcare.

Prior to her appointment as Director of the USC Norris Comprehensive Cancer Center, Associate Dean for Cancer Programs, and H. Leslie and Elaine S. Hoffman Cancer Research Chair at USC’s Keck School of Medicine, Dr. Lerman served as Senior Deputy Director of the Abramson Cancer Center and Vice Dean for Strategic Initiatives in the Perelman School of Medicine at the University of Pennsylvania.
sc ctsi logoPowered by SC CTSI